Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation
- 24 November 1998
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 812 (1-2) , 65-75
- https://doi.org/10.1016/s0006-8993(98)00926-3
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Glutamate agonist activityNeuroReport, 1995
- Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in ratsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1995
- The glycine/NMDA receptor antagonist, R‐(+)‐HA‐966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK‐801) in rodentsBritish Journal of Pharmacology, 1993
- Regulation of excitatory amino acid release by receptors in rat striatum: in vivo microdialysis studiesBrain Research, 1992
- Dopamine in schizophrenia: a review and reconceptualizationAmerican Journal of Psychiatry, 1991
- Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's diseaseTrends in Neurosciences, 1990
- A “Glutamatergic Hypothesis” of SchizophreniaClinical Neuropharmacology, 1989
- Dissociative AnesthesiaAnesthesia & Analgesia, 1966
- Observations on the psychotomimetic effects of sernylComprehensive Psychiatry, 1961
- The Effect of 1-Arylcyclohexylamine (Sernyl) on Twelve Normal VolunteersJournal of Mental Science, 1960